Therapeutic effects of short‐ and intermediate‐term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|11|1062-1070

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.11, 2015-11, pp. : 1062-1070

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Indwelling peritoneal catheters in patients with cirrhosis and refractory ascites

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 10, 2015-10 ,pp. : 1026-1031

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intrahepatic shunt & refractory ascites

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 2, 2015-02 ,pp. : 389-395

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tolvaptan treatment for patients with decompensated cirrhosis and advanced hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E161-E162

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased serum C‐reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E311-E319

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cirrhosis regression by lamivudine

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 2, 2015-02 ,pp. : 372-378

John Wiley & Sons Inc

Access to resources Recommend Favorite